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Abstract
Background: Glutathione is a tripeptide composed o f glutamate, cysteine and glycine, 
accomplishing a broad range o f vital functions. Synthesis o f glutathione and cysteine is performed 
mainly in the liver, whereas most other tissues are supplied w ith these thiols via sinusoidal efflux 
into the blood. Since canalicular efflux also occurs, thiols may be present in human bile. However, 
th io l composition o f human gallbladder bile is largely unknown, which makes it difficult to  speculate 
on the exact function o f thiols in bile. In this study we report on the levels o f non-protein bound 
thiols in gallbladder bile o f patients w ith various gastrointestinal disorders.
Methods: Gallbladder bile was obtained after cholecystectomy from 30 patients who were 
operated fo r pancreatic cancer, duodenal cancer, chronic pancreatitis o r cholecystolithiasis. Bile 
was analysed fo r non-protein bound tota l- and oxidised glutathione and related thiols, by high 
performance liquid chromatography.
Results: A  more than I00-fo ld  inter-individual variation in non-protein bound th io l levels was 
found in human gallbladder bile o f patients w ith a variety o f gastrointestinal disorders. Bile did 
contain high amounts o f cysteine, whereas much lower levels o f glutathione, cysteinylglycine and 
homocysteine were detected. Most thiols were present in the ir oxidised forms.
Conclusion: Thiols are present in considerable amounts in human gallbladder bile o f patients w ith 
various gastrointestinal disorders, levels o f cysteine being much higher than those o f glutathione 
and o ther thiols. Most thiols were in the ir oxidised forms, which may indicate the presence o f 
considerable chemical- o r  oxidative stress in the patients studied here.
Background
Glutathione is a tripeptide composed of glutamate, 
cysteine and glycine, that exists in a reduced (GSH) and 
oxidised (GSSG) form. Oxidised glutathione may also 
occur as protein bound glutathione (RSSG). Reduced glu­
tathione is the active form. The most widely recognised 
functions of reduced glutathione are threefold: 1 . main­
taining the (cellular) redox status, which is essential for 
many vital biological functions, 2 . protection of cells and 
tissues against toxic compounds, both of endogenous and
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exogenous origin and, 3. the reservoir function of 
cysteine, an important amino acid and building block of 
most proteins. Since glutathione is more stable and resist­
ant against oxidation than cysteine, it serves as the pre­
ferred form of storage and transport of cysteine [1-3].
Glutathione is synthesized mainly in the liver and after 
sinusoidal efflux from liver into blood plasma, glutath­
ione is transported, hydrolysed and taken up in tissues 
rich in y-glutamyl-transpeptidase (yGT), such as kidney 
and lung. Thus, blood plasma serves as a transport 
medium for glutathione from liver to the various other tis­
sues that are consumers of glutathione and cysteine [4].
In contrast to the hepatic sinusoidal efflux of glutathione, 
the role of the canalicular efflux into bile and intestine is 
less well understood [1 ]. Numerous studies on content 
and composition of glutathione and its metabolites in 
bile have been performed in bile duct canulated animals, 
demonstrating that the glutathione content in bile may be 
very high, depending on species [5]. Furthermore it was 
shown that glutathione in animal bile may be rapidly oxi­
dised and hydrolysed [1]. In rats, the biliary content of 
glutathione was shown to be lower than, but directly pro­
portional to the intrahepatic concentration [6 ]. Adjust­
ment of toxins to rats did increase the biliary excretion of 
oxidised glutathione, thus indicating that biliary levels of 
oxidised glutathione may be a good measure of oxidative- 
or chemical stress [6 ]. This supports the main role of glu­
tathione in detoxification. Animal studies have also sug­
gested that glutathione is an osmotic driving force for the 
bile acid independent bile flow [1-3]. In addition, glutath­
ione and its related thiols cysteine and cysteinylglycine, 
excreted via bile, may be taken up by the (small) intestinal 
epithelium, and it was suggested that this "bilio-entero- 
hepatic cycle" of glutathione and related thiols may func­
tion as an extra reservoir, making more "hepatic" glutath­
ione available for sinusoidal efflux, when needed [1 ].
Since human bile remains in the gallbladder for several 
hours, composition of thiols in the human gallbladder 
bile, apart from inter-individual differences, may also be 
affected by gallbladder motility, inflammatory status, 
presence and number of gallbladder stones, etc. In addi­
tion, since yGT enzyme activity is high in the biliary tree 
of humans, composition of the gallbladder bile may differ 
considerably from that of primary canalicular bile [1,7].
Simultaneous measurements of the levels of total- and 
oxidised glutathione and related thiols in human gall­
bladder bile may enlarge our knowledge on the thiol sta­
tus of the gallbladder, and possibly also that of the liver, 
of a particular patient. The thiol status of gallbladder bile 
may be a reflection of underlying disease, of therapeutic 
intervention in (biliary) disease [7] and may be a measure
of the degree of oxidative- and/or chemical stress of an 
individual. However, hardly any data on the content of 
glutathione and other thiols in human gallbladder bile 
are available so far. Therefore we performed a pilot study 
on the levels and composition of non-protein bound 
total- and oxidised glutathione and related thiols in 
human gallbladder bile, obtained at surgery for pancre­
atic- or duodenal adenoma/carcinoma, chronic pancreati­
tis or cholecystolithiasis.
Methods
Patients
Gallbladder bile was collected after cholecystectomy from 
30 patients, 19 males and 11 females, mean age 55 years 
[range 20-80]. Patients were operated for chronic pancre­
atitis (n = 7), pancreatic cancer (n = 7), duodenal cancer 
(n = 4), duodenal adenoma (n = 3), cholecystolithiasis (n 
= 7) or other reasons (n = 2) at the Department of General 
Surgery, Radboud University Medical Center Nijmegen, 
between Januari 2004 and Januari 2006. In addition to 
the primary diagnoses mentioned above, additional 
cholecystitis and/or cholecystolithiasis were found 
present at pathology in eight of the patients.
The study was approved by the local medical ethical 
review committee (CMO regio Arnhem Nijmegen). Ver­
bal consent for the use of gallbladder specimens was 
obtained from each patient.
Immediately after cholecystectomy, gallbladder bile was 
collected by puncture of the gallbladder. Bile was trans­
ported to the laboratory and handled for assessment of 
total non-protein bound (both reduced and oxidised) and 
oxidised non-protein bound levels of cysteine (Cys and 
oCys), homocysteine (Hcys and oHcys), cysteinylglycine 
(CG and oCG) and glutathione (GSH and GSSG), essen­
tially as described by us for the assay of thiols in whole 
blood [8 ]. In short, for assay of total thiol levels, 100 |iL 
bile was added to 1 0 0  |iL ice-cold 1 2 % perchloric acid 
(PCA) containing 2.0 mM bathophenanthrolinedisul- 
fonic acid (BPDS; Sigma Chemicals, Zwijndrecht, the 
Netherlands). For assay of oxidised thiols, another 100 |iL 
bile was added to 100 |iL 12% PCA containing 2.0 mM 
BPDS and 40 mM N-ethylmaleimide (NEM; Sigma Chem­
icals). After thorough mixing and centrifugation at 16,000 
x g for 20 min and 4°C, supernatants were collected and 
stored at -80°C. Samples were analysed within one 
month. The excess of NEM was removed by adding 70 |iL 
KOH (2.0 M) followed by 60 |iL HCl (0.01 M in 0.3 M 3- 
[N-morpholino]-propanesulfonic acid buffer) to 100 |iL 
of the sample. In the assay, 100 |iL sample or standard was 
reduced by adding 1 0  ^L tris(2 -carboxyethyl)phospine 
(Fluka Chemie AG, Bornem, the Netherlands; 10% (w/v) 
in 0.9% sodium chloride/4.0 mM EDTA) and incubation 
at room temperature for 30 min. After reduction, 100 |iL
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PCA (0.6 M with 1.0 mM EDTA) was added and samples 
were subsequently mixed and centrifuged for 5 min at
10.000 x g. Clear supernatant (100 |iL) was incubated for 
1 hour and 60°C with 240 |iL reaction-mixture containing 
20 |iL NaOH (1.55 M), 200 |iL borate buffer (125 mM 
K2 B4 O 7  4H2O and 4.0 mM EDTA, pH 9.0), and 20 |iL 7- 
fluorobenzofurazane-4-sulfonic acid (Fluka Chemie; 5 
mg/mL in borate buffer). Of the derivatised sample, 20 |iL 
was subjected to high performance liquid chromatogra­
phy with fluorescent detection, using an autosampler 
(Model Marathon, Spark Holland), solvent delivery sys­
tem (High Precision Pump model 480, Gynkotek) and 
fluorescent detector (Intelligent Spectrofluorometric 
Detector model 821-FP, Jasco) operating at excitation and 
emission wavelengths of 385 and 515 nm, repectively. 
The column used was an Inertsil ODS-2, 100 x 3 mm (5 
|im particle size) and a R2 10 x 2 mm guard column, both 
from Chrompack (Middelburg, the Netherlands). The 
total-to-oxidised ratio for each thiol as a measure of oxi­
dative stress was also calculated.
Data obtained were analysed with the Chromeleon chro­
matography data-system (Gynkotek, München, Ger­
many). Thiol levels were calculated using four-point 
calibration curves for each thiol and were expressed in 
|imol/L.
All statistical analyses were performed using SPSS (version 
12.0; SPSS Inc. Chicago, USA). Since multiple testing was 
performed, a p value of less than 0 . 0 1  was considered sig­
nificant.
Results
Median levels and ranges of the total non-protein bound 
and oxidised thiols, glutathione, cysteine, homocysteine 
and cysteinylglycine in gallbladder bile of 30 patients are 
given in Table 1. Median content of cysteine (Cys) was 
found highest (90.1 |imol/L), followed by cysteinylgly­
cine (CG, 11.3 |imol/L) and glutathione (GSH, 7.0 |imol/ 
L), whereas only minor amounts of homocysteine (Hcys, 
0.5 |imol/L) were present in human gallbladder bile. Most 
thiols were present in their oxidised forms; 1 0 0 %, 8 6 % 
and 81% for Hcys, CG and Cys, respectively, except for 
glutathione which was found for only 40% in its oxidised 
form. This trend was also reflected in the median ratios of 
total non-protein bound/oxidised thiol; RCys, RHcys, 
RCG and RGSH, which were 1.3, 0.8, 1.2 and 1.9, respec­
tively.
No associations were found between mean levels of any 
thiol and age, gender or primary diagnosis of the patients. 
Only tendencies for higher levels of total CG (17.2 vs.
24.0 |imol/L, p = 0.026) and oxidised CG (14.4 vs. 21.3 
|imol/L, p = 0.025) were found in male vs. female 
patients, respectively. When the gallbladder bile thiol lev-
T a b le  1: Leve ls  and ra tio s  o f  to ta l  n o n -p ro te in  b o u n d  and 
o x id ise d  th io ls  in  h u m a n  g a llb la d d e r b ile .
Thiol N Median Range
Cys (|xmol/L) 30 90.1 1.4-404
oCys (^mol/L) 30 69.2 0.8-488
R Cys/oCys 30 1.3 0.6-3.8
Hcys (^mol/L) 30 0.5 0.0-2.9
oHcys (^mol/L) 30 0.6 0.0-3.2
R Hcys/oHcys* 22 0.8 0.5-5.0
CG (|xmol/L) 30 1 1.3 0.5-84.0
oCG (|xmol/L) 30 .98. 1.3-81.3
R CG/oCG 30 1.2 .8
T
.40.
GSH (^rio l/L ) 30 7.0 0.0-106
GSSG (^rio l/L ) 30 2.7 0.0-34.2
R GSH/GSSG* 25 1.9 0.5-5.3
*N ote that some ratios (Hcys/oHcys and GSH/GSSG) could not be 
calculated due to  the presence of zero values.
els of patients without gallbladder pathology (n = 15) 
were compared with those of patients with cholecystitis 
with/or without cholecystolithiasis (n = 15), tendencies 
for lower total glutathione (21.4 vs. 12.7 ^mol/L, p = 
0.050) and lower oxidised glutathione levels (8.2 vs. 5.4 
|imol/L, p = 0.067) in patients without gallbladder 
pathology were noticed.
Discussion
The composition of human gallbladder bile with respect 
to glutathione and related thiols was studied. Earlier data 
on biliary excretion of glutathione or related thiols and 
their composition in bile were obtained almost exclu­
sively from studies on laboratory animals, mainly rats. 
Except from other species differences between humans 
and rats, a main difference is the absence in rats of a gall­
bladder as a reservoir of bile. Another important differ­
ence is that most animal studies in general are performed 
on completely homogeneous study populations, showing 
relatively little variations between individual animals, 
which all receive the same standard diet, whereas in our 
study gallbladder bile of a heterogeneous patient popula­
tion was investigated, which may be a main cause of vari­
ation. Glutathione was found to be the most prominent 
thiol present in bile of rats and mice, followed by CG and 
Cys, whereas in human gallbladder bile levels of Cys were 
highest, followed by CG and GSH, Hcys being hardly 
detectable. In rodents, concentrations of glutathione in 
bile were in the order of several mmol/L [1,5,6] whereas 
in human gallbladder bile, glutathione concentrations of 
only up to 0.1 mmol/L were found. These large differences 
may be either the result of species differences between 
humans and rodents, may be due to the various (gallblad­
der) disorders of the patients studied here, or may depend 
on the high levels of y-glutamyl-transpeptidase in the bil­
iary tree or gallbladder epithelium of humans, which may 
lead to rapid degradation of glutathione into GC and Cys.
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Thiol levels of gallbladder bile showed considerable inter­
individual variation; several hundred-fold for Cys and CG 
whereas GSH values varied between 0-106 |imol/L. It 
should be noted once again, that the gallbladder bile 
investigated here was not obtained from healthy individ­
uals but from patients with a variety of serious gastrointes­
tinal diseases, which could contribute significantly to the 
huge inter-individual variation in thiol levels. Animal 
studies suggested that biliary concentrations of thiols may 
reflect the concentrations in the liver [6 ]. When a similar 
mechanism is present in humans, this would mean that 
hepatic concentrations are critically low in some of the 
patients investigated here, since very low concentrations 
(<2.5 |imol/L) of glutathione were measured in the gall­
bladder bile of 6  out of 30 individuals.
Also in contrast to the findings in animal studies are the 
much higher amounts of oxidised thiols, detected in 
human bile. Most of Cys, CG and Hcys in human bile is 
present in the oxidised form, whereas in animal bile most 
thiols are present in their reduced state. This could be 
explained by the fact that healthy animals were investi­
gated, having little oxidative or chemical stress, whereas 
the gallbladder bile analysed here was obtained from 
patients after surgery for a variety of reasons. These 
patients were subjected to chemical stress such as anes­
thetics and medication, and oxidative stress as a result of 
the surgical intervention or the underlying disease, in 
most patients being cancer or (severe) inflammatory dis­
ease.
Conclusion
This pilot study on the thiol composition of human gall­
bladder bile, obtained at surgery for a variety of gastroin­
testinal disorders, reveals that:
-Levels of cysteine are highest whereas levels of glutath­
ione and other related thiols are much lower.
-Most thiols are in the oxidised state, possibly indicating 
considerable oxidative or chemical stress in the patients 
under study here.
-Large (several hundred-fold) inter-individual variation in 
thiol levels exists. Whether this large variation may be 
caused by the gallbladder pathology, by the health and 
disease status of the patient, or by biological variation 
between individuals, remains to be investigated.
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